DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Cao R. et al.
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer.

Med Oncol 2015;
32: 325

Download Bibliographical Data

Search in:
Access: